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Background: Gestational Diabetes (GD) has increased over
the last 20 years, affecting up to 15% of pregnant women
worldwide. The complications associated can be reduced with
the appropriate glycemic control during the pregnancy.
Methods: The EU FP7 project ‘MobiGuide: Guiding patients
anytime everywhere’, focuses on GD patients to provide guidance
based on clinical guidelines supported by an intelligent decision-
support system integrated in a mobile application. The application
for GD patients consists of a software implemented on a Smart-
phone running Android from 2.x. The evaluation was performed
with a prototype version with self-explanatory messages to access
each of the scenarios: a) Patients logbook (including glycemia,
diet compliance and exercise); b) Recommendations; c) Settings;
and d) Automatic physical activity monitoring.
We collected feedback on the design and functionality of the
mobile application after the patients interacted with the system,
in order to support subsequent iterations of the application de-
velopment. The system was tested with 8 patients with GD, who
answered a questionnaire about the design, perceived ease of use
and perceived usefulness of the mobile application.
Results: Most patients have shown positive comments. 75.0%
strongly agree that the system will help them to be more confi-
dent with the disease. 87.5% consider that the terminology is
clear and the information is logically shown. And, 75.0% stated
that it will be easy to use and easy to learn the application.
Conclusions: Including patient feedback in design-concept
development is essential to identify critical factors to fulfill us-
ability, ease of use and usefulness requirements.
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Objectives: The role of mobile technology to improve dia-
betes care in adults with type 1 diabetes (REMOTE-T1D) study
was aimed to evaluate the use of mobile technology (iBGStar
[iPhone plus the BGStar]) in improving Patient Reported
Outcomes (PRO).
Methods: This single-center, prospective, randomized, open-
label, investigator initiated pilot study enrolled 100 adult patients
with T1D. Patients were randomized in a 1:1 fashion to an in-
tervention group using self-monitoring of blood glucose
(SMBG) with BG Star and mobile technology (iBG Star) vs.
SMBG with Accu-Chek Nano (Control). All subjects had
similar clinic and phone visits for 3 months with a 3 month
extension period and wore a blinded DexCom Gen4 Platinum
continuous glucose monitor (CGM) for 4 separate 7-day periods.
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